Aurora Cannabis, the Canadian-based leading global medical cannabis company, is pleased to announce a distribution partnership between The Entourage Effect and MedReleaf Australia. The Entourage Effect provides comprehensive distribution and support services to pharmacies in Australia and will serve as a wholesaler for MedReleaf Australia’s leading portfolio of products under the CraftPlant, Aurora, and IndiMed brands, furthering the mission to expand access for Australian patients.
“We are deeply committed to broadening access to premium medical cannabis for the expanding community of patients who rely on Aurora, and we seek the right partners in the markets in which we operate to make this happen,” said Andre Jerome, Executive Vice President, Global Business Development at Aurora. “Our new partnership with The Entourage Effect broadens our already robust distribution in Australia, ensuring even greater access to our high-quality medical cannabis portfolio, reinforcing our commitment to patient care.”
“We are thrilled to be partnering with MedReleaf Australia to facilitate the distribution and wholesaling of their products,” said Lisa Varley, CEO of The Entourage Effect. “This collaboration marks a significant milestone for both companies, underscoring our shared commitment to improving patient access and advancing the Australian medicinal cannabis market. Together, we are well-positioned to better serve the needs of patients across the nation.”
Aurora remains at the forefront of the global medical cannabis industry and is steadfast in supporting the continued growth and development of the rapidly expanding Australian medical cannabis market. MedReleaf Australia, a wholly owned subsidiary of Aurora, is committed to quality, consistency and proudly meets all TGA-GMP standards.
